Peter Marks
Director
Neurology
Prana Biotechnology
Australia
Biography
Mr Marks has served as a director of PRANA Biotechnology since July 2005. For the period November 21, 2006 to October 20, 2011, he has also served as Executive Chairman of iSonea Ltd, formally KarmelSonix Ltd, a medical devices company listed on the ASX that is focused on developing and commercializing a range of devices in the respiratory and medicine space.In his roles with these various financial institutions, he was responsible for advising a substantial number of listed and unlisted companies on issues ranging from corporate and company structure, to valuation, business strategies, acquisitions and international opportunities. He holds a Bachelor of Economics degree, a Bachelor of Law degree and Graduate Diploma in Commercial Law from Monash University in Melbourne, Australia, and an MBA degree from the Scottish School of Business at the University of Edinburgh.
Research Interest
Alzheimer’s and Huntington's diseases, Parkinson’s disease and other movement disorders (PBT434) and brain cancer (PBT519), pre-clinical toxicology testing, Metal Protein Attenuating Compounds,neurodegenerative diseases.
